; and (3) consistent with the findings of studies and research under paragraph (1), in consultation with health and public health professional associations, scientific and medical researchers, and other relevant experts, develop and inform recommendations, guidance, and educational materials on the long-term effects of SARS–CoV–2 infection, which may include conditions that arise as a result of such infection, and provide such recommendations, guidance, and educational materials to health care providers and the general public. (b) Considerations In conducting or supporting research under this section, the Secretary shall consider the diversity of research participants or cohorts to ensure inclusion of a broad range of participants, as applicable and appropriate. (c) Additional activities The Secretary may— (1) acting through the Director of the Agency for Healthcare Research and Quality, conduct or support research related to— (A) the improvement of health care delivery for individuals experiencing long-term health effects of SARS–CoV–2, which may include conditions that arise as a result of such infection; (B) the identification of any trends associated with differences in diagnosis and treatment of the long-term health effects of SARS–CoV–2 infection and related conditions; and (C) the development or identification of tools and strategies to help health care entities and providers care for such populations, which may include addressing any differences identified pursuant to subparagraph (B); (2) publicly disseminate the results of such research